21 CFR Subpart A - General Provisions
prev | next
- § 310.3 Definitions and interpretations.
- § 310.4 Biologics; products subject to license control.
- § 310.6 Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.
The following state regulations pages link to this page.